The real problem lies in how social media reduces an intricate endocrine system to a crude algorithm: stress equals spiked ...
In 2026, disability group II can be assigned for a number of diseases if they cause persistent and pronounced limitations in ...
A new review links polyendocrine metabolic ovarian syndrome, formerly PCOS, to possible elevated risk of Alzheimer's disease ...
Huadong Medicine's Unit Gets Nod to Trial Head, Neck Cancer Treatment MT Sep. 28 Huadong Medicine's Weight Management Drug Shows 'Positive' Results in Third Phase Trial MT Sep. 15 Chinese Drug ...
BioNTech will present Phase 2 clinical trial data on pumitamig combinations for advanced cancers at ESMO 2026.
The gut microbiome changes with age, with microbial diversity and function varying according to health status, diet, ...
As the world celebrates breast cancer awareness month, the physician, philosophy doctoral student, and author of 'Nos corps ...
Drug innovation, biologics, GLP-1 therapies, chronic disease demand, expanded coverage and advanced infrastructure drive US pharmaceutical market growthDublin, Oct. (GLOBE NEWSWIRE) -- "United States ...
AstraZeneca advances its ambition to revolutionize cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...
Late-breaking oral presentation will feature first data from the global ROSETTA Lung-107 Phase 2 clinical trial evaluating pumitamig, a ...
Katelyn Hainesworth and her mother-in-law Donna Rockmore both battled breast cancer in a span of less then 10 years, and now ...
Breast cancer is a formidable disease that affects millions of individuals each year. Data fromm the World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results